| Literature DB >> 24236198 |
Doreen Harcus1, Daniel Dignard, Guylaine Lépine, Chris Askew, Martine Raymond, Malcolm Whiteway, Cunle Wu.
Abstract
The ascomycetes Candida albicans, Saccharomyces cerevisiae and Scheffersomyces stipitis metabolize the pentose sugar xylose very differently. S. cerevisiae fails to grow on xylose, while C. albicans can grow, and S. stipitis can both grow and ferment xylose to ethanol. However, all three species contain highly similar genes that encode potential xylose reductases and xylitol dehydrogenases required to convert xylose to xylulose, and xylulose supports the growth of all three fungi. We have created C. albicans strains deleted for the xylose reductase gene GRE3, the xylitol dehydrogenase gene XYL2, as well as the gre3 xyl2 double mutant. As expected, all the mutant strains cannot grow on xylose, while the single gre3 mutant can grow on xylitol. The gre3 and xyl2 mutants are efficiently complemented by the XYL1 and XYL2 from S. stipitis. Intriguingly, the S. cerevisiae GRE3 gene can complement the Cagre3 mutant, while the ScSOR1 gene can complement the Caxyl2 mutant, showing that S. cerevisiae contains the enzymatic capacity for converting xylose to xylulose. In addition, the gre3 xyl2 double mutant of C. albicans is effectively rescued by the xylose isomerase (XI) gene of either Piromyces or Orpinomyces, suggesting that the XI provides an alternative to the missing oxido-reductase functions in the mutant required for the xylose-xylulose conversion. Overall this work suggests that C. albicans strains engineered to lack essential steps for xylose metabolism can provide a platform for the analysis of xylose metabolism enzymes from a variety of species, and confirms that S. cerevisiae has the genetic potential to convert xylose to xylulose, although non-engineered strains cannot proliferate on xylose as the sole carbon source.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24236198 PMCID: PMC3827475 DOI: 10.1371/journal.pone.0080733
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Plasmids used in this study.
| Plasmid | Description | Reference |
|---|---|---|
| pGEM-HIS1 | pGEM-T (Promega) with | [ |
| pRSARG4Δ SpeI | pRS314 with | [ |
| pSN40 |
| [ |
| pSFS2A |
| [ |
| CIpACT-CYC | ACT1p-CYC1t-RPS1-cURA3 | [ |
| pDH270 | CIpACT-CYC with | This study |
| pDH271 | CIpACT-CYC with | This study |
| pDH275 | CIpACT-CYC with | This study |
| pDH276 | CIpACT-CYC with | This study |
| pDH277 | CIpACT-CYC with | This study |
| pDH278 | CIpACT-CYC with | This study |
| pDH279 | CIpACT-CYC with | This study |
| pDH280 | CIpACT-CYC with | This study |
| Plate 393 | CIpACT-CYC with | This study |
| Plate 395 | pUC57 with | This study |
| Plate 396 | CIpACT-CYC with | This study |
| pGen5 | pUC57 with | This study |
| pGen6 | pUC57 with | This study |
| pGen7 | pUC57 with | This study |
| pGen8 | pUC57 with | This study |
Oligonucleotides used in this study.
| Name | Sequence | Gene |
|---|---|---|
| MR2305 |
|
|
| MR2306 |
|
|
| MR2307 |
|
|
| MR2308 |
|
|
| MR2309 |
|
|
| MR2310 |
|
|
| MR2311 |
|
|
| MR2312 |
|
|
| MR2313 |
|
|
| MR2314 |
|
|
| MR2315 |
|
|
| MR2316 |
|
|
| MR2511 |
|
|
| MR2512 |
|
|
| MR2004 |
|
|
| MR2005 |
|
|
| MR2357 |
|
|
| MR2358 |
|
|
| MR1322 |
|
|
| MR1323 |
|
|
| MR1324 |
|
|
| MR1325 |
|
|
| ODH322 |
|
|
| ODH323 |
|
|
| ODH326 |
|
|
| ODH328 |
|
|
| ODH352 |
|
|
| ODH353 |
|
|
| ODH354 |
|
|
| ODH355 |
|
|
| ODH346 |
|
|
| p517 |
|
|
| p544 |
|
|
| p565 |
|
|
| p641 |
|
|
| p642 |
|
|
| p643 |
|
|
| p644 |
|
|
| p645 |
|
|
| p648 |
|
|
| p649 |
|
|
| p650 |
|
|
| p657 |
|
|
| p658 |
|
|
Lower case letters are restriction sites.
Strains used in this study.
| Strain | Genotype | Reference |
|---|---|---|
| CBS 6054 |
| ATCC 58785 |
| SC5314 |
| [ |
| BY4741 |
| [ |
| BY4743 |
| [ |
| SN148 |
| [ |
|
| SN148 | This study |
|
| SN148 | This study |
|
|
| This study |
| CDH120 |
| This study |
| CDH116 |
| This study |
| CDH139 |
| This study |
| CDH128 |
| This study |
| CDH129 |
| This study |
| CDH130 |
| This study |
| CDH131 |
| This study |
| CDH140 |
| This study |
| CDH141 |
| This study |
| CA220 |
| This study |
| CA227 |
| This study |
| CA242 |
| This study |
| CA243 |
| This study |
Figure 1Xylose entry to the PPP pathway and xylose metabolizing capacities of different ascomycetes.
A) The schematic presentation of conserved genes encoding enzymatic activities for the xylose entry into the PPP pathway in ascomycetes. C. a for Candida albicans, S. c for Saccharomyces cerevisiae, and S. s for Schefferomyces stipitis. B) Growth of C. albicans (SC5314), S. stipitis (CBS6054) and S. cerevisiae (BY4741) in SC with 2% xylose or 0.5% xylulose. Strains were grown aerobically at 30°C and the optical density measured over a period of six days, n=3.
Figure 2Transcription profile of C. albicans and S. cerevisiae in xylose
A) From microarray experiments with C. albicans grown in xylose, 175 genes have at least a 2-fold transcription increase in xylose when compared to cells in dextrose. The 44 genes with more than a 5-fold induction in xylose (SX) are shown with their corresponding value. Data for S. cerevisiae is shown for comparison, and in gray-shade if no reciprocal best-hit ortholog is found. B) Transcription modulation of the S. cerevisiae sugar transporters in xylose. The data from the microarray experiments in xylose (SX) and in no-sugar condition (S) is shown for 18 members of the sugar transporter family, relative to cells in dextrose. HXT5 and HXT2 are likely induced due to the absence of dextrose (glucose). HXT6, HXT7 and HXT4 are induced specifically by the presence of xylose. HXT4, HXT1 and HXT3 show a transcriptional reduction only for the no-sugar condition (S), likely due to the absence of sugar. A summary for the transporters description from SGD is reported in the ‘SGD description’ column.
Figure 3The xylose reductase and xylitol dehydrogenase genes from S. stipitis complement C. albicans deletion mutants of the equivalent genes.
(A) S. stipitis XYL1 (CDH120), and (B) S. stipitis XYL2 (CDH116) complement the C. albicans gre3 and xyl2 deletion mutants respectively. (C) The S. stipitis XYL1-XYL2 module (CA242) complements the C. albicans gre3 xyl2 double deletion mutant. Strains were grown aerobically at 30°C in SC with 2% xylose (SX) or 2% xylitol (ST). The optical density was measured over a period of up to 14 days, n=3.
Figure 4The xylose reductase and xylitol dehydrogenase genes from S. cerevisiae complement C. albicans deletion mutants of the equivalent genes.
(A) S. cerevisiae GRE3 (CA255), and (B) S. cerevisiae SOR1 (CDH139) complement the C. albicans gre3 and xyl2 deletion mutants respectively. Strains were grown aerobically at 30°C in 2% xylose (SX) or 2% xylitol (ST). The optical density was measured over a period of 14 days, n=3.
Figure 5The xylose isomerase gene XYLA from Piromyces sp. complements a double gre3/xyl2 deletion or single gre3 deletion in C. albicans.
Growth analysis in synthetic medium (SC) with 2% xylose as the sole carbon source for C. albicans strains: gre3-9 (gre3 deletion), gre3/xyl2-3 (gre3 xyl2 double deletion), CDH128 (gre3/xyl2-3 with the integrated Pir.XYLA) and CDH140 (gre3-9 with the integrated Pir. XYLA). The optical density was measured over a period of 6 days, n=3.